Dosage forms and method for ameliorating male erectile dysfunction
CA 2188385 C · Owner: Queen'S University At Kingston · Inventors: Morales, Alvaro; Adams, Michael A.; El-Rashidy, Ragab
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Pyschogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated whithout, substantial undesirable side effects by sublingual administration of apomorphine dosage forms that contain about 2.5 to about 10 milligrams of apomorphine and dissolve within a time period of about 2 to about 5 minutes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 21, 1995 and granted July 11, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 21, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 21, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.